Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: PTC Therapeutics Inc., 3 years.
PTC Therapeutics Inc.
Director
Editas Medicine Inc.
Director
Whitehawk Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 15, 2024 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| May 23, 2023 | PTC Therapeutics Inc. | Option exercise | +157 | $33.63 | $5,280 |
| May 23, 2023 | PTC Therapeutics Inc. | Open-market sale | −157 | $59.52 | $9,345 |
| May 23, 2023 | PTC Therapeutics Inc. | Option exercise | +1,093 | $33.02 | $36,091 |
| May 23, 2023 | PTC Therapeutics Inc. | Open-market sale | −1,093 | $59.53 | $65,066 |
| May 23, 2023 | PTC Therapeutics Inc. | Option exercise | +1,402 | $33.63 | $47,149 |
| May 23, 2023 | PTC Therapeutics Inc. | Open-market sale | −1,402 | $59.54 | $83,475 |
| May 22, 2023 | PTC Therapeutics Inc. | Option exercise | +173 | $33.63 | $5,818 |
| May 22, 2023 | PTC Therapeutics Inc. | Open-market sale | −173 | $59.52 | $10,297 |
| May 22, 2023 | PTC Therapeutics Inc. | Option exercise | +2,995 | $33.02 | $98,895 |
| May 22, 2023 | PTC Therapeutics Inc. | Open-market sale | −2,995 | $59.53 | $178,292 |
| May 22, 2023 | PTC Therapeutics Inc. | Option exercise | +3,948 | $33.63 | $132,771 |
| May 22, 2023 | PTC Therapeutics Inc. | Open-market sale | −3,948 | $59.53 | $235,024 |
| Apr 21, 2023 | PTC Therapeutics Inc. | Open-market sale | −4,228 | $55.04 | $232,709 |
| Apr 21, 2023 | PTC Therapeutics Inc. | Open-market sale | −100 | $55.57 | $5,557 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.